Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca's: study, 15 April
According to the study, 4 in 1 million people experience cerebral venous thrombosis after getting the Pfizer or Moderna vaccine, versus 5 in 1 million people for the AstraZeneca vaccine. The risk of getting CVT is much higher for those who get COVID-19 -- 39 in a million patients -- than it is for those who get vaccinated.
CVT statistical analysis, January 20, 2020 and March 25, 2021
cohorts:  Pfizer BNT162b2, Moderna mRNA-1273 (N=489,871); AstraZeneca ChAdOx1 nCoV-19 (N=34M), Janssen Ad26.COV2-S (N=N/A)
controls: influenza (N=172,742), COVID-19 (N=513,284)
The risk of being diagnosed with a CVT was significantly higher in the two weeks after COVID-19 compared to influenza or after receiving an mRNA vaccine. The  risk associated  with  COVID-19 was  also  higher than:(a) that currently reported by the EMA following vaccination with the ChAdOx1 nCoV-19 vaccine;(b) the overall incidence observed inthe TriNetX network or (c) the historical incidence of CVT in the USA.
 
by Cat on Mon Apr 19th, 2021 at 09:30:10 PM EST
[ Parent ]

Others have rated this comment as follows:

ATinNM 4

Display:

Occasional Series